FDA Drug Application (202100) for QUILLIVANT XR by NEXTWAVE PHARMS

Back to FDA Applications sponsored by NEXTWAVE PHARMS

Application Number202100
Product Number001
FormFOR SUSPENSION, EXTENDED RELEASE;ORAL
Dosage5MG/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameQUILLIVANT XR
Active IngredientMETHYLPHENIDATE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient METHYLPHENIDATE HYDROCHLORIDE12


Back to FDA Applications sponsored by NEXTWAVE PHARMS